This content is machine translated Advanced hormone-sensitive prostate cancer Sustained testosterone reduction without injections Since January 1, 2024, the oral GnRH antagonist Relugolix has been approved in Switzerland for the treatment of adults with advanced hormone-sensitive prostate cancer [1, 2]. This gives patients access…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia (CLL) One year of first-line therapy for CLL for the prospect of more than 5 years of treatment freedom¹ The BCL2 inhibitor venetoclax has been approved in Switzerland as a first-line therapy for chronic lymphocytic leukemia (CLL) since November 16, 2023 [2]. This is based on the results of…
View Post 5 min This content is machine translated SGDV Congress 2023: Psoriasis and atopic dermatitis On the trail with Sherlock Holmes and CSI – Mystery cases solved At the “somewhat different” AbbVie Symposium at this year’s Swiss Dermatology Congress (SGDV Congress) in Lausanne, experts did some excellent detective work: a missing person was found and the mysteriously…
View Post 5 min This content is machine translated S2k Guideline Reflux New significance of alginates in reflux treatment Alginates offer an alternative option for the treatment of reflux symptoms and are the drug of choice for pregnant women with reflux symptoms. The new version of the “S2k guideline…
View Post 7 min This content is machine translated Annual Meeting of the Swiss Society of Rheumatology (SGR Congress) The treatment landscape for chronic inflammatory rheumatic diseases offers scope for individual treatment decisions With the ongoing expansion of the therapeutic landscape, treatment management for chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) is also changing.…
View Post 11 min This content is machine translated Ankylosing spondylitis Therapy progress with JAKi and earlier diagnosis The treatment of ankylosing spondylitis (AS) is primarily aimed at using anti-inflammatory medication to relieve pain and prevent the development of ankylosis [1]. In this interview, Prof. Dr. Denis Poddubnyy…
View Post 5 min This content is machine translated Atopic dermatitis Achieving high treatment goals with the Minimal Disease Activity concept Patients with moderate to severe atopic dermatitis suffer from the physical and psychological effects of the disease and yet do not receive adequate treatment with systemic therapies, or often only…
View Post 9 min This content is machine translated Sponsored Content: Olfactory dysfunction Options against the loss of smell The sense of smell plays an important role in everyday life: it warns us of sometimes life-threatening dangers such as spoiled food, smoke or fires as well as toxins. This…
View Post 2 min This content is machine translated Webcast Dr. Braun & Prof. Marzolini COVID-19 in everyday practice: the treatment option with PAXLOVID®. Antiviral medications may be used in COVID-19 patient:s at increased risk for severe disease progression.1, 2 The antiviral PAXLOVID® (nirmatrelvir [PF-07321332] / ritonavir) is the only oral COVID-19 therapy approved…
View Post 2 min This content is machine translated Patient case Breast carcinoma with disseminated osteoblastic metastasis. More than 70% of breast cancer sufferers are diagnosed as hormone receptor positive and HER2 negative (HR+/HER2-) [1]. Clinical trial data show that a therapy combination with CDK4/6 inhibitors can…
View Post 1 min This content is machine translated Acute myeloid leukemia Therapy – if intensive chemotherapy is not possible AML predominantly affects older individuals, who are often not suitable for intensive chemotherapy due to their age and pre-existing conditions. Younger patients may also be ineligible for intensive chemotherapy due…
